|
⚲
|
| Keyboard |
| China Pharma Holdings Inc
✚
|
|
|---|---|
| CIK # | 0001106644 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001106644] | |
| 10-Q | [0001106644] | |
| 3 | [0001106644] | |
| 4 | [0001106644] | |
| 8-K | [0001106644] | |
| D | [0001106644] | |
| SC 13G | [0001106644] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Liu Tao Chengdu | |
| China Pharma Holdings Inc | |
| Li Zhilin | |
| Deng Ke | |
| Waung Frank |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
China Pharma Holdings Inc CPHI
Common Stock
|
2023-09-29 | Grant | 13,757,063 | $0.14 | 1,925,989 |
|
China Pharma Holdings Inc CPHI
Common Stock
|
2021-09-09 | Grant | 1,760,000 | $0.67 | 1,179,200 |
|
China Pharma Holdings Inc CPHI
Common Stock
|
2020-12-23 | Grant | 2,000,000 | $0.00 | |
|
China Pharma Holdings Inc CPHI
Common Stock
|
2012-04-28 | Grant | 100,000 | $0.00 | |
|
China Pharma Holdings Inc CPHI
Stock Option(Right to Buy) · derivative
|
2011-05-25 | Disposed to issuer | 25,000 | $0.00 | |
|
China Pharma Holdings Inc CPHI
Stock Option(Right to Buy) · derivative
|
2010-04-28 | Disposed to issuer | 150,000 | $0.00 | |
|
China Pharma Holdings Inc CPHI
Stock Option(Right to Buy) · derivative
|
2009-10-13 | Disposed to issuer | 10,000 | $0.00 |